BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 24, 2026
Home » Newsletters » BioWorld Asia

BioWorld Asia

March 30, 2005

View Archived Issues

Evolutec Finds Better Reception, Raises £9.5M In Private Round

LONDON - Evolutec Group plc raised £9.5 million (US$17.7 million) in a secondary fund raising that was more than two times oversubscribed, just seven months after its initial public offering was pegged back from a hoped-for £7.5 million to £5.1 million. (BioWorld International) Read More

EU Leaders Agree To Measures That Would Help Biotechnology

Read More

Model Links Papillomaviruses To Non-Melanoma Skin Cancers

Read More

Prospects For GM Crops In UK Not Encouraging Following Trial

Read More

Borean Pharma Raises EUR4M For Program In Antibody Mimics

Read More

Other News To Note

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 23, 2026
  • Blue brain with computer chip

    Have brain-computer interfaces finally arrived?

    BioWorld
    More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
  • Photo of two people shaking hands near lab equipment

    K2 nabs two Antengene bispecific TCEs in $2B license, option deal

    BioWorld
    MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
  • In the clinic for June 22, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing